Vaccinated Deaths! - Should this happen on First Covid Exposure?
Why Autopsy analysis in Australia and New Zealand is critical
In order to understand the pathophysiological process causing excess deaths across the world, it needs careful analysis of the evidence.
Australia and New Zealand represent a very important area of research, because the population was vaccinated prior to widespread exposure to virus. The post below was done in 2021.
Possible outcomes for the COVID-19 vaccine campaign in Australia
Australia and New Zealand are in an unusual position for this pandemic as their populations are relatively naïve to all variants of the SARS-COV2 virus. This should be an advantage but requires a good understanding of the pathophysiology in COVID-19 in order to choose the correct path.
In scientific terms, these countries represent a challenge study. This is what occurs when the immune system has been stabilized through vaccination and then exposed to virus for the first time.
“Since the 18th century, deliberate infection of humans with known or putative pathogenic substances or exposure to presumably infectious persons has been used to further scientific, clinical and public health enquiry. The first true challenge with an infectious agent was performed to assess the safety of variolation for its use in preventing smallpox.8 This work was emulated some years later by Jenner to demonstrate the efficacy of vaccination against smallpox infection. Today, challenge studies continue to provide a valuable role in the assessment of protective immunity by allowing investigators to directly measure the efficacy of vaccine candidates against the infection of interest.”
Darton, Thomas C., et al. "Design, recruitment, and microbiological considerations in human challenge studies." The Lancet infectious diseases 15.7 (2015): 840-851.
Prior to Omicron Exposure, over 90% of the New Zealand population was vaccinated against COVID-19.
What were the outcomes?
Similar levels of COVID-19 across the population
Similar numbers of cases of severe COVID-19
Increased excess mortality across the population
Similar to the studies on vaccine candidates with SARS-COV, there was reduced infection but associated lung immunopathology with exposure to virus. Would the outcomes be the same with newer technology?
Why was a vaccine not developed against SARS-COV?
This question recently came to me as I reflected on the current state of the pandemic and increased excess mortality across the globe. What was the issue with vaccines for SARS-COV? Whilst SARS-COV2 is a novel coronavirus virus, it has 80% similarity to the original SARS-COV virus which caused the epidemic in 2003. Severe acute respiratory syndrome (SARS…
If looking through a conspiracy paradigm, that would have been a deliberate strategy to cause as much disease without clearly being linked to the combination of vaccine and re-exposure.
The figure of 90% vaccinated is actually misleading by the NZ Govt. The figure only reflects 90% 1 dose of the people who interacted with the health system in 12 months prior. There are lots of us unjabbed. First doses 3 million , out of 5 million population, 2nd dose over 2 million, boosters much much smaller numbers, children only approx 159,000 first dose and far less 2nd, as kids were required to have it to play sport etc. Statistics and lies.
Dr. McMillan, is this phenomenon similar to an antibody dependent enhancement of disease picture? I know you did not use the term ADE, but is this what might be going on in your view? Thank you for another great discussion. I love your work more and more all the time. You are one of a kind, sir.